Search Results
Results found for "Dr. Nicola Smith"
- 📰 GPCR Weekly News - January 2 to 8, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
postdoctoral training at Boston Children’s Hospital and Harvard Medical School, he joined the lab of Dr
- 📰 GPCR Weekly News, January 23 to 29, 2023
of Staff Postdoctoral Fellow, Biochemical And Cellular Pharmacology Project Leader, Biology Explore Dr
- 📰 GPCR Weekly News - January 9 to 15, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Monthly AMAs where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
, you’re also unlocking over 500 minutes of exclusive, expert-led content from thought leaders like Drs
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
It's starting to look a lot like Christmas at Dr. GPCR!
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- GPCR Buzz of the Week | Sep 23 - 29, 2024
live and work in a developing country, please complete this form to enjoy complimentary access to Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- Adhesion GPCR Consortium Newsletter - May 2024
postdoctoral training, I joined one of the labs that participated in Latrophilins’ discovery, the lab of Dr
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Nicolas, L.; Tinel, N.; Boisseau, C.; Yverneau, P.; Charrier-Savournin, F.; Fink, M.; Trinquet, E.
- Chemokine receptor-targeted drug discovery: progress and challenges
the engagement of the receptor with a certain effector, thus enriching a specific signaling pathway (Smith
- Therapeutic validation of an orphan G protein‐coupled receptor
studies have also reported GPR84 involvement in pain, atherosclerosis, and even metabolic disorders (Nicol
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
previously established chemical space, limiting their ability to identify truly novel chemotypes”(Thomas, Smith
